| Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study D Daoussis, SNC Liossis, AC Tsamandas, C Kalogeropoulou, A Kazantzi, ... Rheumatology 49 (2), 271-280, 2010 | 466 | 2010 |
| Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis D Daoussis, SNC Liossis, EE Solomou, A Tsanaktsi, K Bounia, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 286 | 2010 |
| Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis D Daoussis, SC Liossis, AC Tsamandas, C Kalogeropoulou, ... Clinical and Experimental Rheumatology-Incl Supplements 30 (2), S17, 2012 | 228 | 2012 |
| A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease D Daoussis, K Melissaropoulos, G Sakellaropoulos, I Antonopoulos, ... Seminars in arthritis and rheumatism 46 (5), 625-631, 2017 | 215 | 2017 |
| Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment GE Fragoulis, C Liava, D Daoussis, E Akriviadis, A Garyfallos, ... World journal of gastroenterology 25 (18), 2162, 2019 | 198 | 2019 |
| The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? D Daoussis, AP Andonopoulos Seminars in arthritis and rheumatism 41 (2), 170-177, 2011 | 138 | 2011 |
| Biologics in SAPHO syndrome: a systematic review D Daoussis, G Konstantopoulou, P Kraniotis, L Sakkas, SN Liossis Seminars in arthritis and rheumatism 48 (4), 618-625, 2019 | 111 | 2019 |
| Targeting CD40L: a promising therapeutic approach D Daoussis, AP Andonopoulos, SNC Liossis Clinical and Vaccine Immunology 11 (4), 635-641, 2004 | 109 | 2004 |
| Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis D Daoussis, AP Andonopoulos, SNC Liossis Seminars in arthritis and rheumatism 39 (5), 369-383, 2010 | 96 | 2010 |
| Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis AP Andonopoulos, N Meimaris, D Daoussis, A Bounas, G Giannopoulos Annals of the Rheumatic Diseases 62 (11), 1116-1116, 2003 | 94 | 2003 |
| Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature D Daoussis, I Antonopoulos, SNC Liossis, G Yiannopoulos, ... Seminars in arthritis and rheumatism 41 (6), 822-829, 2012 | 90 | 2012 |
| The infectious basis of ACPA-positive rheumatoid arthritis LI Sakkas, D Daoussis, SN Liossis, DP Bogdanos Frontiers in microbiology 8, 292296, 2017 | 78 | 2017 |
| Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis D Daoussis, VF Panoulas, I Antonopoulos, H John, TE Toms, P Wong, ... Annals of the rheumatic diseases 69 (3), 517-521, 2010 | 76 | 2010 |
| Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature D Daoussis, SNC Liossis, AC Tsamandas, C Kalogeropoulou, A Kazantzi, ... Seminars in arthritis and rheumatism 40 (2), 127-136, 2010 | 61 | 2010 |
| Intestinal involvement in systemic sclerosis: a clinical review LI Sakkas, T Simopoulou, D Daoussis, SN Liossis, S Potamianos Digestive diseases and sciences 63, 834-844, 2018 | 59 | 2018 |
| Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus S Mavrogeni, L Koutsogeorgopoulou, G Markousis-Mavrogenis, ... Lupus 27 (4), 564-571, 2018 | 59 | 2018 |
| B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence D Daoussis, SNC Liossis, G Yiannopoulos, AP Andonopoulos International journal of rheumatology 2011, 2011 | 51 | 2011 |
| Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases LI Sakkas, D Daoussis, A Mavropoulos, SN Liossis, DP Bogdanos Seminars in arthritis and rheumatism 48 (6), 1133-1141, 2019 | 48 | 2019 |
| Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis D Daoussis, I Antonopoulos, AP Andonopoulos, SNC Liossis Rheumatology 46 (2), 227-231, 2007 | 48 | 2007 |
| The role of platelets in autoimmunity, vasculopathy, and fibrosis: implications for systemic sclerosis K Ntelis, EE Solomou, L Sakkas, SN Liossis, D Daoussis Seminars in Arthritis and Rheumatism 47 (3), 409-417, 2017 | 47 | 2017 |
